Schedule 13G ownership disclosure
Evolent Health Inc
Class A Common Stock · CUSIP: 30050B101
Event date: 2025-11-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rubicon Fund II LP
Shares: 5,032,468.70 · Class: 4.51%
- Rubicon Fund II PF LP
Shares: 783,654.30 · Class: 0.7%
- Rubicon OP GP II LP
Shares: 5,816,123.00 · Class: 5.21%
- Rubicon OP GP II LLC
Shares: 5,816,123.00 · Class: 5.21%
- Rubicon Founders LLC
Shares: 5,816,123.00 · Class: 5.21%
- Boehler Adam
Shares: 5,816,123.00 · Class: 5.21%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-25-014793
- Form type
- SCHEDULE 13G
- Filer
- Boehler Adam
- CIK
- CIK 1982325
- Filed
- Nov 14, 2025
- Reporting period
- Nov 13, 2025
- Description
- Schedule 13G beneficial ownership